BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36387061)

  • 1. A Feedback Loop of LINC00665 and the Wnt Signaling Pathway Expedites Osteosarcoma Cell Proliferation, Invasion, and Epithelial-Mesenchymal Transition.
    Bai J; Zhang X; Jiang F; Shan H; Gao X; Bo L; Zhang Y
    Orthop Surg; 2023 Jan; 15(1):286-300. PubMed ID: 36387061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00665 facilitates the progression of osteosarcoma via sponging miR-3619-5p.
    Zhang DW; Gu GQ; Chen XY; Zha GC; Yuan Z; Wu Y
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9852-9859. PubMed ID: 33090388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00665 Facilitates the Malignant Processes of Osteosarcoma by Increasing the RAP1B Expression via Sponging miR-708 and miR-142-5p.
    Wang L; Song X; Yu L; Liu B; Ma J; Yang W
    Anal Cell Pathol (Amst); 2021; 2021():5525711. PubMed ID: 34306997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
    Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
    Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00665 promotes HeLa cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the WNT-CTNNB1/β‑catenin signaling pathway.
    Xia L; Chen YX; Lian JB
    Sheng Li Xue Bao; 2021 Apr; 73(2):233-243. PubMed ID: 33903885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
    Wang H; Zhang P
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
    Bi W; Yang M; Xing P; Huang T
    Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer.
    Zhao X; Weng W; Long Y; Pan W; Li Z; Sun F
    Hum Cell; 2020 Oct; 33(4):1142-1154. PubMed ID: 32776307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA-XIST promotes the oxidative stress-induced migration, invasion, and epithelial-to-mesenchymal transition of osteosarcoma cancer cells through miR-153-SNAI1 axis.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cell Biol Int; 2020 Oct; 44(10):1991-2001. PubMed ID: 32515520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro.
    Han Y; Hu H; Zhou J
    Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation.
    Zhang H; Zhou Q; Shen W
    J Orthop Surg Res; 2022 Jul; 17(1):344. PubMed ID: 35799265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.